Richard Manning, Alan Alford, and Richard Sciacca were commissioned by Pfizer Inc. to coauthor two papers on tax inversions.
“Tax Inversions: A Preliminary Review of Company Financial Data” analyzes the impact of corporate inversions on financial metrics of companies involved in inversions since 2005.
“Tax Inversions: How Do Financial Metrics of Foreign Acquisitions Compare?” evaluates how the metrics of foreign domiciled companies engaged in non inversion-related acquisition of United States target companies behave relative to those of inverting companies and their peers.
Bates White was cited in a March 8 Forbes article titled “Corporate Inversions Are the Symptoms, Bad Tax Policy Is the Disease.”